According to Report Study, the hyperthermia cancer treatment market is predicted to reach US$ 266 Mn by the end of 2030.
According to Report Study, the hyperthermia cancer treatment market is predicted to reach US$ 266 Mn by the end of 2030.
Rise in Investments in Telemedicine for Access to Cancer Care during COVID-19
Healthcare costs seem to have increased for cancer patients amid the ongoing coronavirus situation, since these patients are at the high risk of contracting the infection, owing to low immunity levels. This has created revenue opportunities for companies in the hyperthermia cancer treatment market, as clinicians have boosted their capabilities in telemedicine and other digital platforms to increase accessibility to patient care.
Download Sample @ https://qyresearchmedical.com/sample/111557
Hospitals and specialty clinics are increasing their investments in developing special screening departments for the evaluation of cancer patients with potential COVID-19 symptoms. Such trends are generating business streams in order to revive growth of the hyperthermia cancer treatment market. However, many clinics have limited and even excluded the amount of visitors that are at the low risk of COVID-19.
Scientists Address Undesired Crystalline Phases in Glass Ceramics for Hyperthermia Techniques
Companies in the hyperthermia cancer treatment market are increasing their R&D in new treatment options for patients. This has led to the emergence of glass ceramics for hyperthermia techniques, owing to their advantages of biocompatibility, bioactivity, and osteoproductivity. However, scientists are yet to explore ways to prevent the occurrence of undesired crystalline phases in the material. Companies are partnering with researchers and scientists to prevent the magnetite oxidation to hematite, which can emerge, while undergoing the heat treatment.
The hyperthermia cancer treatment market is slated to register a favorable CAGR of ~6% during the forecast period. This is evident since glass ceramics in hyperthermia techniques are capable of raising the temperature of cancerous tissues high enough to destroy it.
Deep Tissue Thermal Therapy Holds Promising Potentials in Breast Cancer Treatment
The hyperthermia cancer treatment market is predicted to reach US$ 266 Mn by the end of 2030. The deep tissue thermal therapy is gaining prominence in the cancer treatment space, especially among patients with breast cancer. The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), U.S., is gaining recognition for its comprehensive and individualized thermal therapy works. This indicates that med-tech companies are unlocking growth opportunities in the U.S., since North America is anticipated to dictate the highest revenue share among all regions in the market. The deep tissue therapy is being combined with the proton therapy to improve medical outcomes.
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111557/2900
Ultrasound Hyperthermia Devices Provide Quality Assurance for Treatment of Cancer Patients
The therapeutic application of heat is found to be effective in cancer treatment. Hence, med-tech companies in the hyperthermia cancer treatment market are increasing their production capacities in high quality heating equipment to enable precise thermal dosimetry. This has led to innovations in antennas and power delivery systems that provide adequate quality assurance for the treatment of cancer patients.
High intensity focused ultrasound (HIFU), nanoparticle heating, and scanned focused ultrasound (SFUS) techniques are broadening revenue streams for companies in the hyperthermia cancer treatment market. As such, ultrasound hyperthermia devices are predicted to dominate the second highest revenue among all device types in the market.
Strong R&D in Operating Principles of Internal Heating Techniques Improves Medical Outcomes
Combination treatments such as hyperthermia with chemotherapy via controlled localized heating can be achieved with the help of radiofrequency (RF) and microwave. Recent advancements in radiofrequency and microwave mediated hyperthermia include applicators that are most suitable for superficial hyperthermia. On the other hand, internal heating or deep hyperthermia is being combined with brachytherapy i.e. a needle-shaped antenna/electrode that can be implanted directly in the tissue or inserted via catheters.
The high variety in applicator designs for internal heating such as microwave antennas, capacitive-coupled RF catheter-based electrodes, and ultrasound systems are creating value grab opportunities for companies in the hyperthermia cancer treatment market. Med-tech companies are gaining a strong research in operating principles of internal heating techniques and other devices.
Analysts’ Viewpoint
Telemedicine and mobile apps are offering wellness and stress management resources to cancer patients amid the ongoing COVID-19 pandemic. Companies in the hyperthermia cancer treatment market are benefitting with the help of the deep tissue thermal therapy, owing to its non-invasive nature that omits the need of anesthesia. However, radiation dose weighting-based on clonogenic cell survival analysis alone may not be sufficient to predict treatment efficacy. Hence, companies in the hyperthermia cancer treatment market should increase their R&D in more sophisticated biological dose concepts based on spheroid data to improve patient outcomes. Glass ceramics are a breakthrough innovation in the hyperthermia cancer treatment that hold promising potentials with advancements in biomaterial R&D.
Hyperthermia Cancer Treatment Market: Overview
Hyperthermia is a form of therapy where heat is used to enhance effectiveness of radiation and chemotherapy, and to destroy tumors. Hyperthermia is most often used to treat tumors that are close to the surface of the body. In the hyperthermia treatment, the tumor area is heated to a temperature of 40 degree Celsius to 43 degree Celsius (104 degree Fahrenheit to 109 degree Fahrenheit) for approximately one hour.
Recently, several clinical trials showed that hyperthermia with radiation therapy and/or chemotherapy for the treatment of recurrent breast cancer, melanoma, head & neck cancer, prostate, cervix, and other sites of locally advanced or recurrent cancers provides additional benefits with lower side effects to destroy cancer cells
Different types of devices used for hyperthermia treatment includes infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others
The global hyperthermia cancer treatment market has experienced significant growth in the last decade due to rise in prevalence of various types of cancer and favorable policies
Hyperthermia Cancer Treatment Market: Drivers
Rise in prevalence and incidence of cancers such as breast, liver, soft tissue sarcoma, head & neck tumors, prostate cancer, and others drives demand for hyperthermia cancer treatment. According to the National Cancer Institute (NIH), an estimated 1,806,590 cases are expected to be diagnosed in the U.S. in 2020, with prostate, lung, and colorectal cancer likely to account for 43% of the total cancer cases in men. More than 60% of the world’s new cancer cases occur in Africa, Asia, and Central and South America, and 70% of the total cancer deaths globally occur in these regions.
Increase in the geriatric population directly affects the global hyperthermia cancer treatment market. The population aged 65 years and above has higher cancer incidence and mortality rate than younger people. Around 60% of cancer conditions occur among the geriatric population, 10 to 11 times higher than in the younger population.
Market Segmentation: Hyperthermia Cancer Treatment Market
In terms of device type, the global hyperthermia cancer treatment market has been divided into infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others. The microwave hyperthermia devices segment is projected to dominate the global hyperthermia cancer treatment market during the forecast period.
Based on treatment method, the global hyperthermia cancer treatment market has been bifurcated into locoregional and whole-body. The locoregional segment has been split into external & interstitial, intraluminal or endocavitary methods, continuous hyperthermic peritoneal perfusion (CHPP), and deep tissue & regional perfusion.
In terms of application, the global hyperthermia cancer treatment market has been classified into breast cancer, liver cancer, soft tissue sarcoma, head & neck tumors, prostate cancer, and others
Based on end user, the global hyperthermia cancer treatment market has been categorized into hospitals & specialty clinics, ambulatory surgical centers, and others. The hospitals & specialty clinics segment dominated the global hyperthermia cancer treatment market in terms of revenue in 2019.
Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and expected revenue (US$ Mn) for each of these segments from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.
Regional Overview: Hyperthermia Cancer Treatment Market
In terms of region, the global hyperthermia cancer treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
The current and expected market revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2030, with their CAGRs from 2020 to 2030
The study also offers a list of recommendations, highlights, and useful insights of the global hyperthermia cancer treatment market, which would help new companies willing to enter the market and existing companies to increase market shares and in the decision-making process
Hyperthermia Cancer Treatment Market: Major Players
The hyperthermia cancer treatment market report concludes with the company profiles section, which includes key information about major players in the global hyperthermia cancer treatment market
Leading players analyzed in the hyperthermia cancer treatment market report include
- Pyrexar Medical
- Celsius42 GmbH
- Hydrosun GmbH
- Oncotherm Kft
- Andromedic S.r.l.
- Yamamoto Vinita Co., Ltd.
- Chongqing Haifu Medical Technology Co., Ltd.
- innoMedicus Ltd.
- Gamida
- RanD
Each of these players has been profiled in the hyperthermia cancer treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments
Key Questions Answered in Hyperthermia Cancer Treatment Market Report
- What is the sales/revenue generated by hyperthermia cancer treatment across all regions during the forecast period?
- What are the opportunities in the global hyperthermia cancer treatment market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which device type segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Hyperthermia Cancer Treatment Market – Segmentation
Device Type
- Infrared Hyperthermia Devices
- Ultrasound Hyperthermia Devices
- Microwave Hyperthermia Devices
- Others
Treatment Method
- Locoregional Method
- External & Interstitial
- Intraluminal or Endocavitary Methods
- Continuous Hyperthermic Peritoneal Perfusion (CHPP)
- Deep Tissue & Regional Perfusion
- Whole-body
Application
- Breast Cancer
- Liver Cancer
- Soft Tissue Sarcoma
- Head & Neck Tumors
- Prostate Cancer
- Others
End User
- Hospitals & Specialty Clinics
- Ambulatory Surgical Centers
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111557/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/